Abstract: The current invention provides thermosensitive liposomes and formulations thereof preferably for treating, ameliorating, delaying, curing and/or preventing cancer.
Type:
Application
Filed:
July 6, 2021
Publication date:
May 30, 2024
Applicant:
Thermosome GmbH
Inventors:
Martin Hossann, Barbara Cornelia Wedmann, Lars Hartwin Lindner, Wouter Jacobus Marinus Lokerse
Abstract: The invention relates to stereospecific lipids for the locoregional therapy with long-term circulating stimuli-sensitive nanocarrier systems. A preferred embodiment thereof is a thermosensitive liposome for treating tumors, especially urinary bladder tumors and other localized tumors.
Abstract: The invention relates to stereospecific lipids for the locoregional therapy with long-term circulating stimuli-sensitive nanocarrier systems. A preferred embodiment thereof is a thermosensitive liposome for treating tumors, especially urinary bladder tumors and other localized tumors.